Lanean...
3K3A-activated protein C variant does not interfere with the plasma clot lysis activity of tenecteplase
BACKGROUND AND PURPOSE —: A recombinant engineered variant of activated protein C (APC), 3K3A-APC, lacks anticoagulant properties (<10%) while preserving APC’s anti-inflammatory, anti-apoptotic, and neuroprotective functions and is very promising in clinical trials for ischemic stroke. Therapeuti...
Gorde:
| Argitaratua izan da: | Stroke |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7380733/ https://ncbi.nlm.nih.gov/pubmed/32568648 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.120.028793 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|